A phase I clinical trial of tiopronin, a putative neuroprotective agent, in aneurysmal subarachnoid hemorrhage

Neurosurgery

Volumn 67, Issue 1, 2010, Pages 182-185

  Kim, Grace H ^a   Kellner, Christopher P ^a   Hickman, Zachary L ^a   Zacharia, Brad E ^a   Starke, Robert M ^a   Hwang, Brian Y ^a   Ducruet, Andrew F ^a   Fernandez, Luis ^a   Mayer, Stephan A ^a   Tracey, Kevin J ^a   Connolly, E Sander ^b  

^a Department of Medicine   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Aneurysm; Neuroprotection; Subarachnoid hemorrhage; Tiopronin

Indexed keywords

NEUROPROTECTIVE AGENT; TIOPRONIN;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BRAIN ARTERY ANEURYSM; CLINICAL ARTICLE; CLINICAL TRIAL; CYSTINURIA; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; ALDEHYDES; BRAIN ISCHEMIA; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; PROPYLAMINES; SUBARACHNOID HEMORRHAGE; TIOPRONIN; VASOSPASM, INTRACRANIAL;

EID: 77954096982     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000370919.93259.3C     Document Type: Article

References (8)

1. Kassell N F, Sasaki T, Colohan AR, Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke. 1985;16(4):562-572.
2. Solenski NJ, Haley EC Jr, Kassell N F, et al. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med. 1995;23(6):1007-1017.
3. Seiler N. Polyamine oxidase, properties and functions. Prog Brain Res. 1995;106:333-344.
4. Ivanova S, Botchkina GI, Al-Abed Y, et al. Cerebral ischemia enhances polyamine oxidation: identification of enzymatically formed 3-aminopropanal as an endogenous mediator of neuronal and glial cell death. J Exp Med. 1998;188(2):327-340.
5. Ivanova S, Batliwalla F, Mocco J, et al. Neuroprotection in cerebral ischemia by neutralization of 3-aminopropanal. Proc Natl Acad Sci USA. 2002;99(8):5579-5584.
6. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke. 1999;30(12):2752-2758.
7. Pak CY, Fuller C, Sakhaee K, Zerwekh JE, Adams BV. Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. J Urol. 1986;136(5):1003-1008.
8. Lindell A, Denneberg T, Jeppsson JO. Urinary excretion of free cystine and the tiopronin-cysteine-mixed disulfide during long term tiopronin treatment of cystinuria. Nephron. 1995;71(3):328-342.